By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel is largely bearish on Astronics (ATRO), citing high valuation, thin margins, significant debt, and potential risks from customer concentration and volatile backlog conversion.
Risk: Significant long-term debt relative to net income and potential cash flow fragility.
Opportunity: Potential margin expansion via operating leverage on the backlog.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Pertento Partners acquired 815,333 shares of Astronics last quarter; the estimated trade size was $59.07 million based on quarterly average prices.
The quarter-end value of the position changed by $54.41 million, reflecting both share purchases and price appreciation.
The new stake places outside the fund’s top five holdings.
On May 14, 2026, Pertento Partners disclosed a new position in Astronics (NASDAQ:ATRO), acquiring 815,333 shares in the first quarter, an estimated $59.07 million trade based on quarterly average pricing.
According to a May 14, 2026, SEC filing, Pertento Partners LLP initiated a new position in Astronics by purchasing 815,333 shares. The estimated transaction value was $59.07 million, calculated using the quarterly average share price. The quarter-end value of the stake was $54.41 million, reflecting both the share count and stock price movements during the period.
NASDAQ:PSMT: $78.96 million (8.38% of AUM)
As of Friday, Astronics shares were priced at $80.86, up 170% over the past year and well outperforming the S&P 500, which is instead up about 28%.
| Metric | Value | |---|---| | Price (as of Friday) | $80.86 | | Market capitalization | $2.9 billion | | Revenue (TTM) | $886.8 million | | Net income (TTM) | $45.4 million |
Astronics operates at scale within the aerospace and defense sector, serving a global customer base with a focus on advanced electronic systems and test solutions. The company leverages its engineering expertise to address the evolving needs of commercial, military, and general aviation markets. Its diversified product offering and established relationships with OEMs and government entities provide a strong competitive position in specialized, high-reliability applications.
Astronics shares have already delivered huge gains, and Pertento appears to be betting that the company's operating momentum still has room to run.
Earlier this month, the company reported first-quarter sales growth of 12% to $230.6 million, while net income nearly tripled to $25.5 million. Even more impressive, bookings reached a record $290.4 million, and backlog climbed to an all-time high of $734.3 million, giving management unusually strong visibility into future demand.
Much of that strength is coming from commercial aerospace, where demand for seat motion, in-flight connectivity, lighting, and safety products remains robust. Aerospace operating margins expanded to 16.5%, while management raised full-year revenue guidance to $970 million to $1 billion.
For long-term investors, the key question is whether the company can convert its record backlog into sustained earnings growth. Pertento's willingness to establish a sizeable new position during a steep rally suggests it believes Astronics is still in the early innings of a broader aerospace recovery rather than nearing the end of one.
Before you buy stock in Astronics, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Astronics wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $477,813! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,320,088!
Now, it’s worth noting Stock Advisor’s total average return is 986% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 23, 2026. *
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Astronics, Cellebrite, Ies, and Primo Brands. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"ATRO's valuation after the 170% surge leaves scant room for any slowdown in aerospace spending."
Pertento's $59M ATRO purchase after a 170% run looks like momentum chasing rather than deep value. The stock now trades at roughly 3.3x TTM revenue and 64x net income against $970M-$1B 2026 guidance. Record backlog is real, yet aerospace cycles have repeatedly shown that OEM and airline capex can stall quickly on fuel spikes, labor costs, or recession signals. With the stake outside the fund's top five, conviction appears modest. Investors should watch Q2 margin sustainability and whether commercial bookings decelerate from the $290M print.
The article already flags the post-rally entry and record backlog, so the risk of an immediate reversal may be overstated if defense and connectivity orders keep compounding.
"ATRO's backlog visibility is genuine, but the stock's 170% surge has already priced in most of the near-term upside; further gains require proof that margins stay above 15% through a potential aerospace slowdown."
Astronics' 170% one-year surge, combined with record $734M backlog and 16.5% aerospace margins, does suggest genuine operational momentum—not pure speculation. Pertento's $59M entry during a rally is noteworthy but not necessarily contrarian; it could reflect FOMO rather than deep conviction. The real test: can ATRO convert backlog to 15%+ EBIT margins sustainably? At $2.9B market cap with $45M TTM net income (1.5% net margin), the stock prices in near-perfect execution. Commercial aerospace demand is cyclical; one geopolitical shock or airline capex pullback could crater multiples fast. The article omits valuation entirely—no P/E, no EV/EBITDA. That's a red flag.
A $59M position from a $940M AUM fund entering a 170% rally-runner is classic late-cycle behavior. If Pertento has conviction, why isn't ATRO in the top five holdings? The backlog is impressive but backlog ≠ profit—execution risk, supply chain delays, and margin compression on large contracts are real.
"At a 64x trailing P/E, the market has already priced in a best-case scenario, leaving zero margin of safety for operational hiccups or supply chain volatility."
Astronics (ATRO) is currently trading at roughly 64x trailing earnings, a valuation that assumes flawless execution on its $734M backlog. While Pertento’s entry is a signal of confidence, chasing a 170% rally requires more than just 'strong visibility'—it requires margin expansion to prove the operating leverage is real. With TTM net income at $45.4M on $886M revenue, the 5.1% net margin is razor-thin for a company in a high-capital-intensity sector. If aerospace supply chain bottlenecks persist or if R&D costs for next-gen avionics spike, that record backlog could become a liability rather than a catalyst. Investors are paying a premium for growth that is already priced in.
The record backlog provides a multi-year revenue floor that significantly derisks the company compared to typical growth stocks, potentially justifying a higher valuation multiple as earnings scale.
"Astronics' backlog and recent revenue gains do not guarantee sustained profitability; the 170% 1-year rally implies significant downside risk if aerospace demand softens or margins compress."
Pertento's new ATRO stake signals belief in an ongoing aerospace cycle, but several risk factors are glossed over in the piece. Astronics' momentum rests on backlog conversion and a favorable mix, yet backlog can be volatile and bookings don’t guarantee cash flow or sustained margins. The stock is up roughly 170% in 12 months, suggesting high embedded expectations and limited upside if demand slows or input costs rise. The article omits sensitivity to defense budgets, commercial-aircraft cycles, and supplier concentration risks; it also glosses over the lack of detailed forward guidance and potential earnings volatility if Q2-Q4 results disappoint.
However, the obvious reading may be overweight. The rally could be a multiple-expansion bet on aerospace cyclicality rather than durable earnings, and a hiccup in bookings or a downturn in defense spending could trigger sharp downside.
"Customer concentration in aerospace poses a sharper threat to the backlog than the margin or cyclical risks already discussed."
Gemini flags the 5.1% net margin as problematic, but overlooks Claude's 16.5% operating margins potentially expanding via operating leverage on the backlog. Nobody has raised customer concentration: a delay from key OEMs or carriers could unwind the $734M visibility quicker than macro cycles. Pertento's stake suggests they're pricing in that margin expansion despite the 170% run-up.
"Customer concentration risk is the single biggest threat to backlog realization, and no panelist has quantified or stress-tested it."
Grok raises customer concentration—valid—but undersells the risk. ATRO's top-5 customers likely represent 60%+ of revenue; a single OEM production delay (Boeing 737 MAX, Airbus supply chain) could crater backlog conversion by 30-40% within quarters. The $734M visibility evaporates fast if one anchor customer stutters. Pertento's $59M entry doesn't hedge this idiosyncratic risk; it assumes smooth execution across multiple dependencies simultaneously.
"The company's high leverage makes it hypersensitive to any slowdown in backlog conversion, turning a cyclical risk into a solvency concern."
Claude and Grok are fixated on OEM delays, but you’re all ignoring the balance sheet. ATRO carries significant long-term debt relative to its $45M net income. In a high-rate environment, servicing this leverage while scaling production is a massive friction point. If backlog conversion slows, interest coverage ratios will tighten immediately. Pertento isn't just betting on aerospace demand; they are betting that ATRO can deleverage through cash flow before the next cycle turns. It’s a liquidity trap waiting to happen.
"Backlog plus elevated debt and rising interest costs imply cash-flow fragility; margin expansion isn't guaranteed, so the 64x earnings multiple hinges on fragile FCF."
Gemini rightly flags ATRO's debt risk, but the bigger omission is cash flow fragility. Backlog isn't cash; in a high-rate cycle, interest costs and working-capital needs can squeeze FCF, undermining any margin expansion needed to sustain a 64x earnings multiple. If Pertento is banking on deleveraging or durable margins, it requires a clear, scalable cash-flow path—otherwise the stock risks multiple compression even with strong backlog.
The panel is largely bearish on Astronics (ATRO), citing high valuation, thin margins, significant debt, and potential risks from customer concentration and volatile backlog conversion.
Potential margin expansion via operating leverage on the backlog.
Significant long-term debt relative to net income and potential cash flow fragility.